US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist

13.800
-0.130-0.93%

Close Mar 27 16:00 ET

13.800
0.0000.00%

Post 20:01 ET

1.89BMarket Cap-2.68P/E (TTM)

Arrowhead Pharmaceuticals Stock Forum

Teddy123

Mar 10 19:34

Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy

$Arrowhead Pharmaceuticals (ARWR.US)$
Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy

Teddy123

Mar 6 21:47

Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases

$Arrowhead Pharmaceuticals (ARWR.US)$
Can These Two RNAi Drugs Revolutionize Obesity Treatment? Arrowhead's Promising Data

Teddy123

Feb 25 20:41

Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity

$Arrowhead Pharmaceuticals (ARWR.US)$
Can Arrowhead's New Obesity Drug Outperform GLP-1s? Preclinical Data Shows Key Advantage

Bellaah

Feb 14 04:44

$Arrowhead Pharmaceuticals (ARWR.US)$ up up

Profit Sucker

Feb 13 00:07

$Arrowhead Pharmaceuticals (ARWR.US)$ all the bullish signal and yet keep going down lol

Mr Whiteside

Nov 22, 2024 23:29

$Arrowhead Pharmaceuticals (ARWR.US)$ $50

stockhub

Apr 8, 2024 00:23

Hope price action is consistent with result

Plozasiran reduced triglycerides and APOC3 up to a mean maximum of 86% and 90% respectively in patients with severe hypertriglyceridemia
$Arrowhead Pharmaceuticals (ARWR.US)$

Mooers' Insights

Tonyco

Apr 7, 2024 11:01

$Arrowhead Pharmaceuticals (ARWR.US)$
Insiderd selling shares and financials dont look good. Im guessing they dont have anything in the pipeline?

Moomoo AI

Mar 8, 2024 19:54

The company's poor performance and the CEO's high pay, despite falling earnings and shareholder value, may upset shareholders. The upcoming AGM on March 14th is a chance for shareholders to hold the board and management accountable.